Igf in Prostate Cancer - A Transgenic Study

Kaplan, Paula J.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Postdoctoral Individual National Research Service Award (F32)
• Project #: 1F32CA074589-01
• Application #: 2012563
• Study Section: Special Emphasis Panel (ZRG2-END (01))
• Project Start: 1998-02-25
• Budget Start: 1997-09-01
• Budget End: 1998-08-31
• Support Year: 1
• Fiscal Year: 1997

Institution

• Name: Baylor College of Medicine
• Department: Anatomy/Cell Biology
• Type: Schools of Medicine
• DUNS #: 074615394
• City: Houston
• State: TX
• Country: United States
• Zip Code: 77030

Publications

Kaplan-Lefko, P J; Sutherland, B W; Evangelou, A I et al. (2008) Enforced epithelial expression of IGF-1 causes hyperplastic prostate growth while negative selection is requisite for spontaneous metastogenesis. Oncogene 27:2868-76

Kaplan, P J; Mohan, S; Cohen, P et al. (1999) The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Cancer Res 59:2203-9